These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37845572)

  • 1. Perfecting antibodies with language models.
    Outeiral C; Deane CM
    Nat Biotechnol; 2024 Feb; 42(2):185-186. PubMed ID: 37845572
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody Administration for Bone Tissue Engineering: A Systematic Review.
    Hosseinpour S; Rad MR; Khojasteh A; Zadeh HH
    Curr Stem Cell Res Ther; 2018; 13(4):292-315. PubMed ID: 29412118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discussion on the Chinese edition of the WHO Standard Acupuncture Point Locations in the Western Pacific Region].
    Qiu T; Li L
    Zhongguo Zhen Jiu; 2011 Sep; 31(9):827-30. PubMed ID: 21972638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies.
    Wherry JC; Pennington JE; Wenzel RP
    Crit Care Med; 1993 Oct; 21(10 Suppl):S436-40. PubMed ID: 8403981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic therapeutic antibodies.
    Sidhu SS; Fellouse FA
    Nat Chem Biol; 2006 Dec; 2(12):682-8. PubMed ID: 17108986
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical knowledge and the improvement of vernacular languages in the Habsburg Monarchy: a case study from Transylvania (1770-1830).
    Sechel TD
    Stud Hist Philos Biol Biomed Sci; 2012 Sep; 43(3):720-9. PubMed ID: 22595134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunization with aerosols. IV. Perfecting equipment of production of vaccine aerosols].
    Fontanges R; Brunat WR; Duprat J; Jacob F; Fournier JM; Roumesy B; Guillon C
    Ann Inst Pasteur (Paris); 1970 Jun; 118(6):815-24. PubMed ID: 5429046
    [No Abstract]   [Full Text] [Related]  

  • 8. Perfecting research techniques in an imperfect world: response to MacWhinney & Snow.
    Edwards JA
    J Child Lang; 1993 Feb; 20(1):209-16. PubMed ID: 8454684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody markup language (AbML) - a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw).
    Sweet-Jones J; Ahmad M; Martin ACR
    MAbs; 2022; 14(1):2101183. PubMed ID: 35838549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.
    Dixit R; Herz J; Dalton R; Booy R
    Vaccine; 2016 Feb; 34(9):1152-61. PubMed ID: 26802604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic antibodies in multiple sclerosis.
    Goebels N; Becher B
    Neurodegener Dis; 2008; 5(1):5-7. PubMed ID: 18075268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Suppression of experimental autoimmune encephalomyelitis with antibodies against adhesion molecules].
    Kawai K; Kobayashi Y; Miyasaka M; Yoshikai Y; Sobue G
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1504. PubMed ID: 8752445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characterization of platelet aggregation-inducing factor podoplanin and development of its antibodies].
    Kato Y
    Seikagaku; 2013 Apr; 85(4):261-5. PubMed ID: 23717871
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein language models guide directed antibody evolution.
    Singh A
    Nat Methods; 2023 Jun; 20(6):785. PubMed ID: 37296342
    [No Abstract]   [Full Text] [Related]  

  • 15. Of mice and MS. Antibodies cure a crippling disorder--but not in people.
    Rennie J
    Sci Am; 1990 Jul; 263(1):25. PubMed ID: 2374900
    [No Abstract]   [Full Text] [Related]  

  • 16. The rollercoaster ride to anti-cancer antibodies.
    Weiner LM; Carter P
    Nat Biotechnol; 2003 May; 21(5):510-1. PubMed ID: 12721576
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous immune globulin: fighting antibodies with antibodies.
    Dahl MV; Bridges AG
    J Am Acad Dermatol; 2001 Nov; 45(5):775-83. PubMed ID: 11606935
    [No Abstract]   [Full Text] [Related]  

  • 18. Are therapeutic antibodies still patentable at the European Patent Office?
    Allen V; Lewis GM
    Pharm Pat Anal; 2017 May; 6(3):91-94. PubMed ID: 28485666
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies in cancer treatment-II.
    Desoize B
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):208-9. PubMed ID: 17986426
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies as leading tools to unlock the therapeutic potential in human disease.
    Martin F
    Immunol Rev; 2016 Mar; 270(1):5-7. PubMed ID: 26864100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.